Laurus Synthesis Inc., the US affiliate of Laurus Labs Private Limited, India, officially opened earlier this month at its more than 10,000- square-foot facility in Woburn, Massachusetts. In addition to offices and administrative space, the site features a large portfolio of laboratory space with appropriate air and water treatment capabilities.

The Grand Opening event was hosted by Dr. Satyanarayana Chava, founder and CEO, Laurus Labs, India; Chandrakanth Chereddi, vice president, synthesis business unit, Laurus Labs, India; Stuart Needleman, president, Laurus Synthesis Inc., Woburn, Massachusetts; and Kevin Duffield, vice president, operations, Woburn, Massachusetts. Approximately 50 pharmaceutical and biotech executives attended the event, learning about the company's capabilities, taking tours of the facilities, and networking with their colleagues at an afternoon reception.

Laurus Synthesis Inc. offers specialized laboratory services that assist clients in advancing their concepts to the next milestone including process development, method development, impurity identification services, and route selection for active pharmaceutical ingredients. Laurus Synthesis Inc. also provides intermediates and key starting materials, as well as the collaborative service capabilities of Laurus Labs in India, including smooth technical transition for scale-up and commercialization.

Source: Laurus Synthesis